Literature DB >> 2954439

Immunoglobulin-specific suppressor T cells.

R G Lynch.   

Abstract

This article has considered evidence that supports the occurrence and functional importance of suppressor T cells that are directed to B cell targets. Cells with these features have been demonstrated in experimental animals and in humans. The designation "suppressor" comes from the serologic phenotype of these cells as well as from their functional property of noncytotoxic inhibition of B cell function. Distinct suppressor T cells with these properties have been identified that effect antigen-, idiotype-, isotype-, and allotype-specific suppression of B cell function. While such cells had been suspected from earlier studies of normal immune responses, the development of monoclonal B cell models using tumor cells has provided a means to readily detect these suppressor T cells and to investigate the mechanisms by which they mediate their effects. Tumor models have proved to be powerful tools in the effort to identify and analyze the elements that underlie the complexity of immune responses. Combined with the insights provided by molecular genetic approaches and flow cytometry, functional and responsive lymphoid tumor cells are being used with increasing frequency to address basic immunoregulatory issues. An important family of suppressor T cells with B cell targets are those that express surface Fc receptors, elaborate immunoglobulin-binding factors, and appear to participate in the regulation of immunoglobulin heavy chain class expression. In addition to their importance in the regulation of heavy chain class expression during normal immune responses, alterations in FcR+ T cells in a number of disease states may provide clues that will lead to a better understanding of disorders of immune regulation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2954439     DOI: 10.1016/s0065-2776(08)60239-4

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


  8 in total

Review 1.  T cell receptor usage in malignant diseases.

Authors:  E Halapi; M Jeddi-Tehrani; A Osterborg; H Mellstedt
Journal:  Springer Semin Immunopathol       Date:  1999

Review 2.  Expression of IgA and IgM Fc receptors on murine T lymphocytes.

Authors:  M Sandor; A Ibraghimov; M G Rosenberg; P Teeraratkul; R G Lynch
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

Review 3.  The biology and pathology of Fc receptors.

Authors:  M Sandor; R G Lynch
Journal:  J Clin Immunol       Date:  1993-07       Impact factor: 8.317

Review 4.  Idiotype-specific T cells in multiple myeloma: targets for an immunotherapeutic intervention?

Authors:  Q Yi; A Osterborg
Journal:  Med Oncol       Date:  1996-03       Impact factor: 3.064

5.  Generation of T cell clones binding F(ab')2 fragments of the idiotypic immunoglobulin in patients with monoclonal gammopathy.

Authors:  A Osterborg; M Masucci; S Bergenbrant; G Holm; A K Lefvert; H Mellstedt
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

6.  Naive idiotype-specific CD4+ T cells and immunosurveillance of B-cell tumors.

Authors:  G F Lauritzsen; S Weiss; Z Dembic; B Bogen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

7.  Selective elimination of idiotype-binding cells in vivo by a drug-idiotype conjugate demonstrates the functional significance of these cells in immune regulation.

Authors:  M M Abu-Hadid; R B Bankert; G L Mayers
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

8.  A self-reactive class I-restricted T-cell response of H-2b mice to determinants of the V beta 8.2 domain of the T-cell receptor for antigen.

Authors:  A Kuhröber; R Schirmbeck; J Reimann
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.